Nachrichten zur Eli Lilly & Co. Aktie

Opening Bell: Merck & Co, Spotify, Intel, Amazon, Eli Lilly, Southwest Airlines, Hasbro

Trotz der guten Bilanzen von Microsoft und Alphabet ging es gestern für den Dow Jones abwärts. Er verlor 0,7 Prozent.…

Is Eli Lilly Stock a Strong Buy After Q1 Earnings?

Lillys mixed Q1 report contains some important info for long-term investors....…

Eli Lilly posts Q1 contraction amid hit to COVID sales

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Regains Full Rights Of REZPEG From Eli Lilly, Plans To Initiate Phase 2b Study

WASHINGTON (dpa-AFX) - Nektar Therapeutics (NKTR) Thursday announced that it will be regaining the full rights to REZPEG from Eli…

Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds

Eli Lilly plans to complete its application for FDA approval of tirzepatide in the coming weeks and expects regulatory action…

Zura Bio Inks License With Eli Lilly, Sets $80 Million Private Placement >ZURA

Zura Bio Inks License With Eli Lilly, Sets $80 Million Private Placement >ZURA...…

Eli Lilly And Co. Q1 Profit Decreases, misses estimates

INDIANAPOLIS (dpa-AFX) - Eli Lilly And Co. (LLY) revealed earnings for first quarter that decreased from last year and missed…

Eli Lilly raises annual profit forecast on strength of diabetes drug

...(Reuters) - Eli Lilly and Co raised its full-year profit forecast......…

Eli Lilly: Tirzepatide Achieves Up To 15.7% Weight Loss In Results From SURMOUNT-2

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) reported that tirzepatide achieved superior weight loss compared to placebo at 72…

Eli Lilly Earnings Are Soon. All Eyes Are on Its Diabetes Drug.

Expectations for first-quarter sales of its diabetes treatment, Mounjaro, are $433 million....…

Why Eli Lilly Stock Is Under Pressure Today

Investors are worried that the drugmaker wont hit Wall Streets top- and bottom-line targets when it reports 2023 Q1 earnings…

Why Earnings Season Could Be Great for Eli Lilly (LLY)

Eli Lilly (LLY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings…

Eli Lilly to sell Baqsimi diabetes drug to Amphastar for around $1 ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eli Lilly (LLY) to Report Q1 Earnings: Will It Beat Estimates?

Higher demand for its key drugs is likely to have offset generic competition for several drugs and may have boosted…

Eli Lilly Divests Low Blood Sugar Drug Baqsimi To Amphastar For $500M Cash

Coca-Cola stock rises on forecast-beating results; Bed Bath & Beyond shares slump and other stocks on the move

Coca-Cola, Bed Bath & Beyond, Foghorn Therapeutics and Eli Lilly are among the biggest moving stocks on Monday....…

Eli Lilly to Sell Baqsimi Product to Amphastar >LLY AMPH

Eli Lilly to Sell Baqsimi Product to Amphastar >LLY AMPH...…

Eli Lilly to sell low blood sugar drug to Amphastar

...(Reuters) -Eli Lilly and Co will sell its low blood sugar drug......…

UPDATE 1-Eli Lilly to sell low blood sugar drug to Amphastar

...(Adds details and background) April 24 (Reuters) - Eli Lilly and Co......…

Eli Lilly to sell hypoglycemia treatment for up to $1.1 billion in cash and milestone payments to Amphastar

Shares of Eli Lilly & Co. LLY gained 0.5% in premarket trading Monday, after the drugmaker announced an agreement to…

Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices

Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all…

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could…

Eli Lilly (LLY) Gains As Market Dips: What You Should Know

Eli Lilly (LLY) closed at $370.47 in the latest trading session, marking a +0.15% move from the prior day....…

BeyondSpring Provides Business Update and Reports Year End 2022 Financial Results

- SEED Therapeutics, a BeyondSpring Subsidiary, Achieved Milestones on the Eli Lilly Collaboration...…

Eli Lilly to boost investment in Indiana manufacturing facilities

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eli Lilly To Invest Additional $1.6 Bln, Commits 200 New Jobs At LEAP Innovation Park

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) Monday announced an additional investment of $1.6 billion to add another 200…

Eli Lilly to invest another $1.6 billion, add 200 more jobs to its new manufacturing sites in Indiana

Eli Lilly & Co. LLY said Monday that it will invest an additional $1.6 billion into its two new manufacturing…

Eli Lilly to invest additional $1.6 bln in 2 new plants

...April 17 (Reuters) - Eli Lilly and Co said on Monday it will invest......…

The Zacks Analyst Blog Highlights Eli Lilly, Thermo Fisher Scientific, Lockheed Martin, Boston Scientific and Canadian Pacific Railway

Eli Lilly, Thermo Fisher Scientific, Lockheed Martin, Boston Scientific and Canadian Pacific Railway are part of the Zacks top Analyst…

Top Analyst Reports for Eli Lilly, Thermo Fisher Scientific & Lockheed Martin

Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Thermo Fisher Scientific…

Precision Cancer Consortium announces new industry member and leadership succession as it celebrates its one-year anniversary

WASHINGTON, April 14, 2023 /PRNewswire/ -- The Precision Cancer Consortium (PCC) is pleased to announce the addition of AstraZeneca as…

dpa-AFX ProFeed